Published Date: 01 Dec 2023
The USA. s. For adult patients who need nirogacestat (Ogsiveo) due to their desmoid tumors progressing, the Food and Drug Administration has approved the tablets.
Read Full News1.
Nirogacestat is approved by the FDA for treating rare non-cancerous soft tissue sarcomas.
2.
Three-Drug Regimens Make Case for a Role in Untreated and Relapsed/Refractory CLL
3.
Transplantation Fails to Improve Survival in Mantle Cell Lymphoma
4.
WHO launches plan for free child cancer medicines
5.
Gene therapy and chemotherapy may be combined in novel ways to treat bone cancer.
1.
Breast Cancer Secrets: AI-Powered Precision Medicine
2.
Can Wearables and AI Become a Gamechanger for Histiocytic Cancer Detection?
3.
Liquid Biopsy in Oncology: Innovations in Cancer Detection, Monitoring, and Clinical Use
4.
The New Frontier of Cancer Survivorship: Navigating the Long-Term Effects of Immunotherapy and Targeted Therapies
5.
The Different Types of Cysts and Why They Occur: Insights from a Dermatologist
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
International Lung Cancer Congress®
1.
Current Scenario of Blood Cancer- Genomic Testing & Advancement in Diagnosis and Treatment
2.
Understanding the Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- PALOMA 2 Study.
3.
Current Cancer Scenario in India- Importance of Genomic Testing & Advancement in Diagnosis and Treatment
4.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VI
5.
Oropharyngeal Cancer in Relation to HPV Status
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation